Defendant

Cipla

2 cases as defendant.

Cases
2
Active
1
1 closed
Filed
2017
Top venue
D. New Jersey
1 case

Celgene Corporation v. Cipla

pending/settled
Docket:
2:20-cv-07759
Court:
D.N.J.
Patents:8530498

Cipla filed an Answer regarding ANDA No. 214618 for 2.5 mg Revlimid. The '498 patent was among the patents-in-suit per Cipla's answer.